FDA EIR - Indivior, Inc. - October 19, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This EIR record concerns Indivior, Inc., with an inspection on October 19, 2017, issued by the Center for Drug Evaluation and Research, covering rx (prescription).

Company: Indivior, Inc.
Inspection Date: October 19, 2017
Product Type: Rx (prescription)
Office: Center for Drug Evaluation and Research
People: Kent Hoffman (other)
Sunita Shinde (company_representative)
Aaron Blackledge (other)
Karen Hojnowski (company_representative)
Mary DeCosta (company_representative)

Open in Dashboard

ID · e6bbda3f-b8b4-47d3-9035-4206b000f5c7

Violation Codes2

21 CFR 312.5021 CFR 312

Full citation text and observation details available on the Dashboard.